Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein L pseudogene 1 (HNRNPLP1) is a genomic pseudogene with sequence similarity to the functional heterogeneous nuclear ribonucleoprotein L (HNRNPL), a well-characterized RNA-binding protein involved in pre-mRNA processing, splicing, and nucleocytoplasmic transport[5]. HNRNPLP1 does not produce an active protein and is not known to participate in any canonical biological functions, pathological processes, or drug interactions. Unlike HNRNPL and other hnRNP proteins, which have major roles in gene regulation and have been associated with neurodegenerative disorders and cancer[1][5], HNRNPLP1 lacks evidence for protein coding or functional participation in any cellular processes. Note: If information was sought on the protein heterogeneous nuclear ribonucleoprotein L or its gene, HNRNPL, extensive details exist regarding its molecular biology, disease roles, and drug relevancy. "HNRNPLP1" designates a nonfunctional pseudogene, and so is not considered a valid therapeutic target nor does it have known clinical or research utility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein L pseudogene 1 (HNRNPLP1).